aspirin and dermatan sulfate

aspirin has been researched along with dermatan sulfate in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's4 (30.77)18.2507
2000's6 (46.15)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ansell, J; Cola, C1
Breimer, DD; Cohen, AF; Danhof, M; de Boer, A; Magnani, HN1
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM1
Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG1
Guyotat, D; Mahul, P; Mazet, E; Mismetti, P; Reynaud, J; Tardy, B; Tardy-Poncet, B1
Chen, AH; Frangos, SG; Sumpio, B1
Boinot, C; Brizard, A; Chamlian, V; Gruel, Y; Guicheteau, M; Macchi, L; Magnin, G; Pourrat, O; Sarfati, R1
Adams, HP; Bendixen, B; Clarke, WR; Hansen, MD; Wilterdink, JL; Woolson, RF1
Allard, S; Cohen, H; de Swiet, M; Letsky, E; Woo, YL1
Bar, J; Blickstein, D; Hod, M1
Carman, TL; Farray, D; Fernandez, BB1
Giannubilo, SR; Tranquilli, AL1

Reviews

4 review(s) available for aspirin and dermatan sulfate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
    American heart journal, 1990, Volume: 119, Issue:2 Pt 1

    Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis

1990
Vascular drugs in the new millennium.
    Journal of the American College of Surgeons, 2000, Volume: 191, Issue:1

    Topics: Abciximab; Animals; Anistreplase; Antibodies, Monoclonal; Anticoagulants; Aspirin; Chondroitin Sulfates; Clopidogrel; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Immunoglobulin Fab Fragments; Intermittent Claudication; Platelet Aggregation Inhibitors; Streptokinase; Ticlopidine; Vascular Diseases; Venous Thrombosis

2000
The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
    Neurologic clinics, 2004, Volume: 22, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain Diseases; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Postoperative Complications; Venous Thrombosis; Warfarin

2004

Trials

4 trial(s) available for aspirin and dermatan sulfate

ArticleYear
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
    Thrombosis and haemostasis, 1991, Aug-01, Volume: 66, Issue:2

    Topics: Adult; Aspirin; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Factor Xa Inhibitors; Glycosaminoglycans; Hemostasis; Heparinoids; Heparitin Sulfate; Humans; Male; Platelet Aggregation; Thromboxane B2

1991
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
    Circulation, 1996, Jan-01, Volume: 93, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Heparitin Sulfate; Hip Fractures; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Thromboembolism

1996
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
    Chest, 1999, Volume: 115, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome

1999
Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST).
    Stroke, 2001, Dec-01, Volume: 32, Issue:12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Chondroitin Sulfates; Confounding Factors, Epidemiologic; Dermatan Sulfate; Drug Administration Schedule; Female; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Survival Rate; Treatment Outcome; United States

2001

Other Studies

5 other study(ies) available for aspirin and dermatan sulfate

ArticleYear
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
    Thrombosis research, 1989, Jun-01, Volume: 54, Issue:5

    Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K

1989
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2000, Volume: 6, Issue:4

    Topics: Adult; Anticoagulants; Aspirin; Asthma; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Risk Factors; Thrombocytopenia; Thromboembolism

2000
Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
    BJOG : an international journal of obstetrics and gynaecology, 2002, Volume: 109, Issue:4

    Topics: Adult; Anticoagulants; Antithrombin III; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Treatment Outcome

2002
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:8

    Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Eczema; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications

2003
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
    Current medicinal chemistry, 2012, Volume: 19, Issue:27

    Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Thrombophilia; Warfarin

2012